Record backlog and LOCUST wins bolster AVAV, but execution risk remains

What happened

AeroVironment reported Q1 FY27 revenue of $480.5 million, up from $454.7 million a year earlier, with funded backlog reaching $1.46 billion and a $464.8 million Army LOCUST production award. The company also secured a first international LOCUST order over $50 million, reinforcing demand for its directed-energy and autonomous systems. Despite these wins, management left full-year guidance unchanged at $2.125–2.225 billion revenue and $305–325 million adjusted EBITDA, implying 55% of revenue and two-thirds of EBITDA must come in 2H FY27. The Q1 beat was offset by SCDE segment revenue falling 21% to $134.5 million and adjusted EBITDA turning negative to -$8.9 million, while inventory jumped to $450 million. Liquidity remains solid with $278.4 million cash and $337 million revolver availability, but material weakness remediation is still ongoing.

Implication

The record backlog and LOCUST awards validate demand, but the unchanged guidance and back-half weighting mean the stock will remain volatile until conversion is proven. If Q2 and Q3 show funded backlog monetizing, inventory growth moderating, and SCDE margins improving, shares could re-rate toward the base-case $155 or even bull-case $180. Conversely, any guidance cut or further inventory build without shipment acceleration would likely push shares toward the bear-case $120, given no margin of safety at current levels. The ongoing material weakness and past restatement add an execution overhang, so position sizing should account for the possibility of another control failure. Overall, the risk/reward is asymmetric if the company can deliver on its 2H ramp, but investors need concrete shipment evidence before adding exposure.

Thesis delta

The thesis is unchanged: buying at $138.9 pays off if AVAV converts its $1.46B funded backlog into the back-half ramp. The new LOCUST orders strengthen the demand side, but they do not yet prove that manufacturing throughput and margin recovery will follow. Consequently, the edge remains dependent on Q2/Q3 execution, not on additional contract wins.